CN103610819B - Chinese medicinal composition for treating vernal keratoconjunctivitis due to pathogenic wind - Google Patents
Chinese medicinal composition for treating vernal keratoconjunctivitis due to pathogenic wind Download PDFInfo
- Publication number
- CN103610819B CN103610819B CN201310685591.6A CN201310685591A CN103610819B CN 103610819 B CN103610819 B CN 103610819B CN 201310685591 A CN201310685591 A CN 201310685591A CN 103610819 B CN103610819 B CN 103610819B
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- medicinal composition
- chinese medicinal
- cold
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal composition for treating vernal keratoconjunctivitis due to pathogenic wind. The Chinese medicinal composition is prepared from asteropyrum cavaleriei, murraya kwangsiensis, Chinese brake herb, wild ginger, tuber fleeceflower stem, raspberry, valerian, silverleaf willow, snake slough and borneol. The Chinese medicinal composition can be clinically used for treating vernal keratoconjunctivitis due to pathogenic wind.
Description
Technical field
The invention belongs to technical field of Chinese medicines, especially relate to a kind of ailment said due to cold or exposure for the treatment of and take advantage of the Chinese medicine composition of attacking type keratoconjunctivitis.
Background technology
Keratoconjunctivitis is ophthalmology common disease, frequently-occurring disease, can cause because of virus or bacteriological infection.Cardinal symptom has hyperemia, pain, photophobia with watery secretion.After morbidity a couple of days, there is disc of confusion point-like epithelial lesions in cornea.Often there is preauricular lymph nodes enlargement, and have tenderness.Doctor trained in Western medicine often uses intravenous injection cedilanid or verapamil, ethamine iodine barks ketone or oral quinidine is controlled, but side effect is very large, and can not effect a radical cure.Drug therapy ailment said due to cold or exposure of the present invention takes advantage of the type keratoconjunctivitis of attacking to reach good effect.
Summary of the invention
The object of the present invention is to provide that a kind of therapeutic effect is good, effective percentage is high, take advantage of the Chinese medicine composition of attacking type keratoconjunctivitis to the treatment ailment said due to cold or exposure of human non-toxic's side effect.
The object of the present invention is achieved like this, according to Chinese medical theory, utilizing the property of medicine of Chinese medicine uniqueness, adopting Rhizoma begoniae pedatifidae lotus, Radix seu Folium Murraya kwangsiensis, Herba Pteridis Multifidae, Herba Asari, Caulis Polygoni Multiflori, Fructus Rubi, Rhizoma et radix valerianae, Salix chienii Cheng, Periostracum Serpentis, Borneolum Syntheticum according to certain compatibility requirement, through being processed into.
Prepare Chinese medicine composition of the present invention to be made up of following raw material medicaments: Rhizoma begoniae pedatifidae lotus 40-60 part, Radix seu Folium Murraya kwangsiensis 30-50 part, Herba Pteridis Multifidae 30-50 part, Herba Asari 20-40 part, Caulis Polygoni Multiflori 20-40 part, Fructus Rubi 20-40 part, Rhizoma et radix valerianae 10-30 part, Salix chienii Cheng 10-30 part, Periostracum Serpentis 10-15 part, Borneolum Syntheticum 10-20 part.
Optimum weight part of traditional Chinese medicinal composition raw materials of the present invention is: 50 parts, Rhizoma begoniae pedatifidae lotus, Radix seu Folium Murraya kwangsiensis 40 parts, Herba Pteridis Multifidae 40 parts, Herba Asari 30 parts, Caulis Polygoni Multiflori 30 parts, Fructus Rubi 30 parts, Rhizoma et radix valerianae 20 parts, Salix chienii Cheng 20 parts, Periostracum Serpentis 12 parts, Borneolum Syntheticum 18 parts.
The pharmacological action of Chinese medicine of the present invention is as follows:
Rhizoma begoniae pedatifidae lotus: heat-clearing and toxic substances removing.For keratitis, pharyngolaryngitis, rhinitis etc.
Radix seu Folium Murraya kwangsiensis: pungent, bitter, slightly warm in nature.Return Liver Channel.Dispelling wind to relieve the exterior syndrome, promoting blood circulation and detumescence.Clinical in flu, measles, keratitis, traumatic injury, the diseases such as fracture.
Herba Pteridis Multifidae: pungent, flat.Disperse exopathogen, regulating qi-flowing for harmonizing stomach.For flu, pharyngitis, conjunctival congestion and swelling pain, stomatitis, toothache, hepatitis, the diseases such as dyspepsia.
Herba Asari: pungent, temperature, mild toxicity.Return lung, kidney, the heart, liver but, spleen channel.Cold expelling dispels the wind, pain relieving, warming the lung to resolve fluid-retention.For exterior syndrome due to wind-cold, headache, toothache, rheumatic arthralgia etc.
Caulis Polygoni Multiflori: sweet, micro-hardship, flat.GUIXIN, Liver Channel.Tranquilizing by nourishing the heart, dispels the wind, dredging collateral.For insomnia, dreaminess, blood deficiency, numbness of the skin, rheumatic arthralgia, the diseases such as rubella pruritus.
Fructus Rubi: sweet, sour, flat.Return liver, kidney channel.The liver and the kidney tonifying, controlling nocturnal emission with astringent drugs reducing urination, improving eyesight.For impotence and premature ejaculation, emission and spermatorrhea, cold womb is infertile, and leukorrhagia is rare clearly, the diseases such as early whitening of beard and hair.
Rhizoma et radix valerianae: acrid, bitter, warm.GUIXIN, Liver Channel.Tranquilizing mind.For irritability, palpitation and insomnia, demented, rheumatic arthralgia, dysmenorrhea, amenorrhea, the diseases such as traumatic injury.
Salix chienii Cheng: pungent, bitter, cold.Heat-clearing and toxic substances removing, dispelling wind for relieving itching, pain relieving.For cold, fever, laryngopharynx swelling and pain, skin pruritus, cystitis, urethritis, traumatic pain.
Periostracum Serpentis: sweet, salty, flat.Return Liver Channel.Dispel the wind, arresting convulsion, nebula removing, antipruritic, removing toxic substances and promoting subsidence of swelling.Twitch for infantile convulsion, cornea cataracta, rubella pruritus, aphtha, furunculosis, the diseases such as scald.
Borneolum Syntheticum: pungent, bitter, cool.GUIXIN, lung meridian.To have one's ideas straightened out refreshment, heat radiation pain relieving, improving eyesight removing nebula.For apoplexy, calentura coma, deafness with qi stagnation, sore throat, aphtha, carbuncle, hemorrhoid, the diseases such as enterobiasis.
The traditional Chinese medical science is thought that ailment said due to cold or exposure is taken advantage of and is attacked type keratoconjunctivitis for being subject to ailment said due to cold or exposure outward, and above attack in order, pathogen contact is popular between eyelid corner of the eyes space between skin and muscles, therefore causes eye itching.Rhizoma begoniae pedatifidae lotus heat-clearing and toxic substances removing in the present invention, for monarch drug, Radix seu Folium Murraya kwangsiensis dispelling wind to relieve the exterior syndrome, Herba Pteridis Multifidae disperses exopathogen, is ministerial drug, Herba Asari cold expelling dispels the wind, Caulis Polygoni Multiflori, Rhizoma et radix valerianae tranquilizing by nourishing the heart, to dispel the wind, Fructus Rubi liver and kidney tonifying, improving eyesight, Salix chienii Cheng heat-clearing and toxic substances removing, dispelling wind for relieving itching, Periostracum Serpentis dispels the wind, nebula removing, antipruritic, Borneolum Syntheticum improving eyesight removing nebula.Find through clinical practice, take advantage of the type keratoconjunctivitis of attacking to have unique curative effect to ailment said due to cold or exposure, effect of heat-clearing and toxic substances removing, dispelling wind for relieving itching, improving eyesight dispelling wind nebula removing played altogether by all medicines, reaches treatment ailment said due to cold or exposure and takes advantage of the object of attacking type keratoconjunctivitis.
Chinese medicine composition of the present invention is taken advantage of in 2010 to 2013 clinical observation ailment said due to cold or exposure and is attacked the routine patient of type keratoconjunctivitis 55, and clinical report is as follows:
1, physical data
In 55 routine patients, in age 18-65 year, the course of disease is many at 1 week to 5 months, 26 years old mean age.
2, diagnostic criteria
2.1 carry out clinical diagnosis with reference to the diagnosis basis in " Chinese medical disease Standardization of diagnosis and curative effect ":
Upper tarsal conjunctiva nipple hypertrophy is flat paving stone sample, or cornea edge glue sample tuberosity; More eosinophilic granulocyte and the eosinophilic granulocyte's tuberosity be dispersed in conjunctival secretion.Ailment said due to cold or exposure is taken advantage of and is attacked type keratoconjunctivitis symptom: two corners of the eyes are had an itch, normal visual acuity, and without red red wet rotten, whole body is levied without deficient and damp and hot.
3, Therapeutic Method
3.1 prescriptions: Rhizoma begoniae pedatifidae lotus 50g, Radix seu Folium Murraya kwangsiensis 40g, Herba Pteridis Multifidae 40g, Herba Asari 30g, Caulis Polygoni Multiflori 30g, Fructus Rubi 30g, Rhizoma et radix valerianae 20g, Salix chienii Cheng 20g, Periostracum Serpentis 12g, Borneolum Syntheticum 18g.
3.2 methods of preparation and use: said medicine routinely technique makes decoction, every day 1 dose, every day 2 times 5 days was 1 course for the treatment of.
4, therapeutic outcome:
4.1 treatment evaluation criterias, judge according to " the Chinese medical disease Standardization of diagnosis and curative effect " that State Administration of Traditional Chinese Medicine formulates:
Cure: clinical symptoms and sign all disappear, vision restoration normal (or vision restoration is to premorbid vision);
Effective: vision improves, and clinical symptoms and sign all disappear;
Effective: clinical symptoms and sign all disappear or partial disappearance or improvement, and vision is without improve;
Invalid: vision without raising or clinical symptoms and sign without improvement or increase the weight of.
4.2 results: in 55 routine patients, cure 30 examples (54.6%), effective 15 examples (27.3%), effective 10 examples (18.1%), and invalid 0 example, total effective rate is 100%.
Model case
1, Wang, man, 29 years old, right eye was very itched, more than the recurrent exerbation moon.Red tongue, thick, yellow and greasy fur, stringy pulse is number slightly.Check: hyperemia of the bulbar conjunctiva, black eyeball central authorities and periphery have the punctate opacity of the cornea of several Semen Sesami size.Vision: right eye 0.12, left eye 1.2, examine for: ailment said due to cold or exposure is taken advantage of and is attacked type keratoconjunctivitis.Above-mentioned symptom after rear 2 courses for the treatment of of taking medicine alleviates, and eye is itched and gone down, and checks that right vision is promoted to 0.8.Continue to take medicine of the present invention, after 1 course for the treatment of, transference cure, follows up a case by regular visits to after 1 year without recurrence.
2, grandson, female, 32 years old, eyes were very itched, existing with headache, heating.Check: binocular vision is 1.0, Dual-eyelid mild swelling, palpebral conjunctiva is obviously congested, and lower eyelid fornix portion has folliculus to be formed, and cornea of left eye has point-like inflammatory infiltration, red tongue, thick, yellow and greasy fur.Take 1 course for the treatment of of medicine of the present invention, every day 1 dose, transference cure, follow up a case by regular visits to after 1 year without recurrence.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is further illustrated, and this embodiment following does not only limit the present invention for illustration of the present invention.
Embodiment 1, treating ailment said due to cold or exposure and take advantage of a Chinese medicine composition of attacking type keratoconjunctivitis, is be made up of Rhizoma begoniae pedatifidae lotus 40g, Radix seu Folium Murraya kwangsiensis 30g, Herba Pteridis Multifidae 30g, Herba Asari 20g, Caulis Polygoni Multiflori 20g, Fructus Rubi 20g, Rhizoma et radix valerianae 10g, Salix chienii Cheng 10g, Periostracum Serpentis 10g, Borneolum Syntheticum 10g.
Embodiment 2, treating ailment said due to cold or exposure and take advantage of a Chinese medicine composition of attacking type keratoconjunctivitis, is be made up of Rhizoma begoniae pedatifidae lotus 50g, Radix seu Folium Murraya kwangsiensis 40g, Herba Pteridis Multifidae 40g, Herba Asari 30g, Caulis Polygoni Multiflori 30g, Fructus Rubi 30g, Rhizoma et radix valerianae 20g, Salix chienii Cheng 20g, Periostracum Serpentis 12g, Borneolum Syntheticum 18g.
Embodiment 3, treating ailment said due to cold or exposure and take advantage of a Chinese medicine composition of attacking type keratoconjunctivitis, is be made up of Rhizoma begoniae pedatifidae lotus 60g, Radix seu Folium Murraya kwangsiensis 50g, Herba Pteridis Multifidae 50g, Herba Asari 40g, Caulis Polygoni Multiflori 40g, Fructus Rubi 40g, Rhizoma et radix valerianae 30g, Salix chienii Cheng 30g, Periostracum Serpentis 15g, Borneolum Syntheticum 20g.
Claims (2)
1. treat ailment said due to cold or exposure and take advantage of a Chinese medicine composition of attacking type keratoconjunctivitis, it is characterized in that it is made up of following raw material medicaments:
Rhizoma begoniae pedatifidae lotus 40-60 part, Radix seu Folium Murraya kwangsiensis 30-50 part, Herba Pteridis Multifidae 30-50 part, Herba Asari 20-40 part, Caulis Polygoni Multiflori 20-40 part, Fructus Rubi 20-40 part, Rhizoma et radix valerianae 10-30 part, Salix chienii Cheng 10-30 part, Periostracum Serpentis 10-15 part, Borneolum Syntheticum 10-20 part.
2. Chinese medicine composition according to claim 1, is characterized in that it is made up of following raw material medicaments:
50 parts, Rhizoma begoniae pedatifidae lotus, Radix seu Folium Murraya kwangsiensis 40 parts, Herba Pteridis Multifidae 40 parts, Herba Asari 30 parts, Caulis Polygoni Multiflori 30 parts, Fructus Rubi 30 parts, Rhizoma et radix valerianae 20 parts, Salix chienii Cheng 20 parts, Periostracum Serpentis 12 parts, Borneolum Syntheticum 18 parts.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310685591.6A CN103610819B (en) | 2013-12-16 | 2013-12-16 | Chinese medicinal composition for treating vernal keratoconjunctivitis due to pathogenic wind |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310685591.6A CN103610819B (en) | 2013-12-16 | 2013-12-16 | Chinese medicinal composition for treating vernal keratoconjunctivitis due to pathogenic wind |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103610819A CN103610819A (en) | 2014-03-05 |
CN103610819B true CN103610819B (en) | 2015-02-18 |
Family
ID=50161552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310685591.6A Expired - Fee Related CN103610819B (en) | 2013-12-16 | 2013-12-16 | Chinese medicinal composition for treating vernal keratoconjunctivitis due to pathogenic wind |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103610819B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105030936A (en) * | 2015-09-15 | 2015-11-11 | 陈丽娟 | Chinese medicine for treating keratoconjunctivitis |
CN106344829A (en) * | 2016-10-08 | 2017-01-25 | 湖北三峡神农生物科技有限公司 | Traditional Chinese medicine composition and production method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1096960A (en) * | 1993-12-06 | 1995-01-04 | 沙洛 | Still bright pacifying smelt medicine and smelt medicated bag and smell medicine container |
CN1159329A (en) * | 1993-05-27 | 1997-09-17 | 陈坤光 | Medicinal liquid for pain and itch |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4933007B2 (en) * | 2001-09-21 | 2012-05-16 | ライオン株式会社 | Ophthalmic composition and method for enhancing antibacterial activity of the composition |
-
2013
- 2013-12-16 CN CN201310685591.6A patent/CN103610819B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1159329A (en) * | 1993-05-27 | 1997-09-17 | 陈坤光 | Medicinal liquid for pain and itch |
CN1096960A (en) * | 1993-12-06 | 1995-01-04 | 沙洛 | Still bright pacifying smelt medicine and smelt medicated bag and smell medicine container |
Non-Patent Citations (3)
Title |
---|
国家中医药管理局《中华本草》编委会.水八角莲、广西九里香、凤尾草、蛇蜕.《中华本草》.上海科学技术出版社,1999,第3卷第303页右栏第34行,第4卷第942页右栏第10-11行,第2卷第123页右栏第1-2行,第9卷第411页左栏第26-28行. * |
王琦妙等.春季角结膜炎中医药治疗最新进展.《中国中医眼科杂志》.2012,第22卷(第3期),第226-229页. * |
项平.第十三节 聚星障.《中医临床实习医师手册》.上海科学技术出版社,2002,(第1版),第866-868页. * |
Also Published As
Publication number | Publication date |
---|---|
CN103610819A (en) | 2014-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103800485B (en) | A kind of Chinese medicine preparation for the treatment of herpes simplex keratitis | |
CN102908603B (en) | Chinese medicament for treating hyperplasia of mammary glands | |
CN106309611A (en) | Plaster with effects of relaxing muscles and stimulating blood circulation | |
CN105477564A (en) | Traditional Chinese medicine composition for treating prosopalgia | |
CN103142879B (en) | Traditional Chinese medicine for treating rubella | |
CN104096192A (en) | Neck-pain patch | |
CN103610819B (en) | Chinese medicinal composition for treating vernal keratoconjunctivitis due to pathogenic wind | |
CN104958448A (en) | Medicine for treating puerperal infection | |
CN104587302A (en) | Traditional Chinese medicine preparation for treating acute appendicitis | |
CN104623376B (en) | Be used for the treatment of prosopalgic medicine | |
CN104274515A (en) | Traditional Chinese medicine for treating cough due to wind-heat affecting lung | |
CN103610987A (en) | Traditional Chinese medicine for treating mumps | |
CN102961539A (en) | Plaster for treating wind-cold-dampness arthralgia and preparation method thereof | |
CN103768368B (en) | A kind of Chinese medicine composition treating acute epididymitis | |
CN104474056A (en) | Traditional Chinese medicine preparation for treating wind-evil attack type keratoconjunctivitis | |
CN106177639A (en) | One treats psoriatic Chinese medicine composition and preparation method thereof | |
CN102940739B (en) | Traditional Chinese medicine composition for treating vernal keratoconjunctivitis | |
CN104857084A (en) | Traditional Chinese medicine medicated bath preparation for treating infantile exogenous fever | |
CN103610797B (en) | Traditional Chinese medicine composition for treating keratoconjunctivitis due to congestion and excess of dampness-heat | |
CN103599498B (en) | Traditional Chinese medicine composition for treating pathogenic wind-heat staying within eyelid type keratoconjunctivitis | |
CN103610772A (en) | Traditional Chinese medicine for treating cerebral thrombosis | |
CN103536708A (en) | Traditional Chinese medicine composition for treating keratoconjunctivitis | |
CN102716421A (en) | Chinese medicine oral liquid for treating flat wart and preparation method of Chinese medicine oral liquid | |
CN105030936A (en) | Chinese medicine for treating keratoconjunctivitis | |
CN105395718A (en) | Externally applied traditional Chinese medicine composition used for treating viral keratitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150218 Termination date: 20171216 |